Stockscreener 앱 받기
48.76
1.74%
-0.75
전일 마감가:
$49.51
열려 있는:
$47
하루 거래량:
135.39K
Relative Volume:
0.34
시가총액:
$1.60B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-13.29
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
+5.39%
1개월 성능:
+18.03%
6개월 성능:
-24.89%
1년 성능:
+63.31%
1일 변동 폭
$47.00
$50.40
1주일 범위
$45.06
$50.66
52주 변동 폭
$28.25
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
48.73 | 1.60B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.42 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.52 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.16 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.32 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times
Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan
JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
When (IRON) Moves Investors should Listen - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World
New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN
Vanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine: Forging Ahead In Hematology (NASDAQ:IRON) - Seeking Alpha
3,700 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Acquired by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Has $622,000 Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc.'s (NASDAQ:IRON) institutional investors lost 21% over the past week but have profited from longer-term gains - simplywall.st
Teacher Retirement System of Texas Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine is Now Oversold (IRON) - Nasdaq
Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada
Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Canada
Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Orbimed advisors sells $310,483 in disc medicine stock - Investing.com India
Disc medicine director Ashiya Mona sells shares worth $310,483 - Investing.com India
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Raymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing - Yahoo
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Ashiya Mona sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com South Africa
OrbiMed Advisors sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com Philippines
Orbimed Advisors LLC Reduces Stake in Disc Medicine Inc: Analyzi - GuruFocus
Ashiya Mona sells $2.83 million in Disc Medicine stock - Investing.com
OrbiMed Advisors sells $2.83 million in Disc Medicine stock - Investing.com
ORBIMED ADVISORS LLC Reduces Stake in Disc Medicine Inc - GuruFocus
(IRON) Trading Advice - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bank of New York Mellon Corp Buys 4,356 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential By Investing.com - Investing.com South Africa
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential - Investing.com
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Disc Medicine Inc 주식 (IRON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Quisel John D | Chief Executive Officer |
Apr 07 '25 |
Option Exercise |
1.01 |
7,000 |
7,070 |
161,828 |
| Ashiya Mona | Director |
Mar 24 '25 |
Sale |
54.11 |
5,738 |
310,483 |
186,541 |
| ORBIMED ADVISORS LLC | Director |
Mar 24 '25 |
Sale |
54.11 |
5,738 |
310,483 |
186,541 |
| Ashiya Mona | Director |
Mar 19 '25 |
Sale |
54.02 |
39,656 |
2,142,217 |
188,981 |
| Ashiya Mona | Director |
Mar 21 '25 |
Sale |
54.00 |
10,011 |
540,594 |
187,297 |
| Ashiya Mona | Director |
Mar 20 '25 |
Sale |
54.01 |
2,762 |
149,176 |
188,617 |
| ORBIMED ADVISORS LLC | Director |
Mar 19 '25 |
Sale |
54.02 |
39,656 |
2,142,217 |
188,981 |
| ORBIMED ADVISORS LLC | Director |
Mar 21 '25 |
Sale |
54.00 |
10,011 |
540,594 |
187,297 |
| ORBIMED ADVISORS LLC | Director |
Mar 20 '25 |
Sale |
54.01 |
2,762 |
149,176 |
188,617 |
| Ashiya Mona | Director |
Mar 10 '25 |
Sale |
54.29 |
202,146 |
10,974,794 |
208,742 |
0.27%
0.30%
자본화:
|
볼륨(24시간):